InMed Pharmaceuticals (MWG.F) Q2 2025 Earnings

13MayConfirmed
Q1 2023
Q4 2024
Q1 2025
Q2 2025
-3.5
-2.91
-2.32
-1.73

Details

Expected EPS
N/A
Actual EPS
-1.7336422
Surprise EPS
-1.73
Surprise Percent
+∞%

Description

InMed Pharmaceuticals (MWG.F) has reported earnings of -1.7336422 per share for Q2 2025.

0 Comments

Share your thoughts